Atorvastatin/Levamlodipine/Telmisartan

阿托伐他汀/左旋氨氯地平/替米沙坦

Report date: 2022/02/11 15:02:33

Base Information

Drug NameAtorvastatin/Levamlodipine/Telmisartan
Drug Alias Name阿托伐他汀/S-氨氯地平/替米沙坦Atorvastatin and Levamlodipine and Telmisartan替米沙坦阿托伐他汀氨氯地平Telmisartan/Atorvastatin/Levamlodipine氨氯地平替米沙坦阿托伐他汀 +[8] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsHMG-CoA reductase inhibitors
TargetsAngiotensin II Receptor Type 1HMG-CoA reductase
Therapy Area/IndicationsDyslipidemiasHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes TelmisartanAtorvastatin Calcium Hydrate
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChong Kun Dang Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChong Kun Dang Pharmaceutical Corp
Active IndicationsN/A
Inactive IndicationsDyslipidemiasHypertension

Other Information

ATC CodeN/A
Related LinksN/A